The genetic epidemiology of neurodegenerative disease
Open accessThe DOI matches its Crossref record; 103 of the 106 references it cites were found in a registry or an index.
Abstract
Gene defects play a major role in the pathogenesis of degenerative disorders of the nervous system.In fact, it has been the very knowledge gained from genetic studies that has allowed the elucidation of the molecular mechanisms underlying the etiology and pathogenesis of many neurodegenerative disorders.In this review, we discuss the current status of genetic epidemiology of the most common neurodegenerative diseases: Alzheimer disease, Parkinson disease, Lewy body dementia, frontotemporal dementia, amyotrophic lateral sclerosis, Huntington disease, and prion diseases, with a particular focus on similarities and differences among these syndromes. The complexities of common diseasesFamilial aggregation had been recognized as a prominent characteristic of many neurodegenerative disorders decades before the underlying molecular genetic or biochemical properties were known.It was often the identification of specific, disease-segregating mutations in previously unknown genes that directed the attention to certain proteins and pathways that are now considered crucial in the pathogenesis of these diseases.These include mutations in the β-amyloid (Aβ) precursor protein, causing Alzheimer disease (AD); in α-synuclein, causing Parkinson disease (PD); or in microtubule-associated protein tau, causing frontotemporal dementia (FTD) with parkinsonism.Another feature observed in most common neurodegenerative diseases -as well as in other common disorders -is a dichotomy between familial (rare) and seemingly nonfamilial (common) forms.The latter are also frequently described as "sporadic" or "idiopathic," although there is a growing body of evidence suggesting that a large proportion of these cases are also significantly influenced by genetic factors.These risk genes are likely to be numerous, displaying intricate patterns of interaction with each other as well as with nongenetic variable, and -unlike classical Mendelian ("simplex") disorders -exhibit no simple or single mode of inheritance.Hence, the genetics of these diseases has been labeled "complex."A popular conception regarding the genetic makeup of complex diseases is the "common disease/common variant" (CD/CV) hypothesis (1).According to this theory common disorders are also governed by common DNA variants (such as single nucleotide polymorphisms.These variants significantly increase disease risk but are insufficient to actually cause a specific disorder.Current empirical and theoretical data support this hypothesis, although there remains great uncertainty as to the number of the underlying risk factors and their specific effect sizes.In this context, it is noteworthy that even recent genetic advances in the study of complex diseases such as AD or diabetes likely only represent the most obvi-ous, most extreme cases of the underlying risk spectrum (Figure 1; ref.2).In AD, for instance, rare, fully penetrant autosomal dominant mutations in 3 genes (i.e.APP, PSEN1, and PSEN2) have been shown to cause the disease, while a common, incompletely penetrant susceptibility variant (i.e., ε4 in APOE; see below) significantly increases the risk for AD.The identification of these genes early in the study of AD genetics was possible due to the combination of several favorable circumstances, such as the presence of multiple independent mutations in the same locus and the availability of extended, multigenerational pedigrees for DNA genotyping and sequencing (in the case of PSEN1) or a large attributable fraction to the overall genetic variance, resulting from relatively high allele frequency and pronounced effect size (in the case of APOE).However, identification of disease genes that make smaller overall contributions to the genetic spectrum (because of only few mutational events; e.g., PSEN2), or risk factors with smaller effect sizes (i.e.odds ratios [ORs] ranging between 2 and 3), will require much larger samples and possibly more sensitive and efficient analytic tools to enable consistent detection across study populations (2).Additional, and commonly cited, problems in finding complex disease genes beyond the most obvious are multiple testing, publication bias, and questionable replication (3-5).Multiple testing can be placed under the larger category of "avoidable false positive" findings, which are also caused by testing insufficiently sized samples, using inappropriate matching of cases versus controls, stratifying populations, and choosing inadequate analysis strategies, etc. Publication bias, on the other hand, which indicates the higher a priori likelihood of a positive finding being published as opposed to a negative one, may have been a possible source of serious bias in the early days.However, there is only relatively little empirical evidence that publication bias actually represents a common or significant source of error in current publications investigating the genetics of a number of disorders (e.g., refs.6-12).The sheer number of publications in the AD gene
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated levels of Amyloid-β (Aβ) peptide initiates a cascade of events that ultimately result in Alzheimer’s disease (AD) [1–4].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 4×
“The most frequently involved gene in recessive parkinsonism is parkin (PRKN) on chromosome 6q25 (33, 41), which causes nearly half of all early-onset PD cases.”
BackgroundInfluentialGoate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 5×
“In AD, for instance, rare, fully penetrant autosomal dominant mutations in 3 genes (i.e. APP, PSEN1, and PSEN2) have been shown to cause the disease, while a common, incompletely penetrant susceptibility variant (i.e., ε4 in APOE; see below) significantly increases the risk for AD.”
BackgroundInfluentialα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · cited 1×
“AD APP (15) Aβ precursor protein 21q21 Dominant Altered Aβ production (Aβ42/Aβ40 ratio ↑) and aggregation AD APOE (21, 22) Apolipoprotein E 19q13 Risk factor Unknown (Aβ aggregation? lipid metabolism?) AD PSEN1 (16) Presenilin 1 14q24 Dominant Altered Aβ production (Aβ42/Aβ40 ratio ↑) AD PSEN2 (17, 18) Presenilin 2 1q…”
BackgroundCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 9×
“In AD, for instance, rare, fully penetrant autosomal dominant mutations in 3 genes (i.e. APP, PSEN1, and PSEN2) have been shown to cause the disease, while a common, incompletely penetrant susceptibility variant (i.e., ε4 in APOE; see below) significantly increases the risk for AD.”
BackgroundInfluential
Research works printed but not linked: 1
- [92]Prusiner, S.B. 1998. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 :13363-13383.
Cited by
Items 601–678 of 678
Ho, W. Y., & Ling, S. (2021) · Neuromethods · doi:10.1007/978-1-0716-1589-8_9
CRISPR/Cas9 system and prospects in animal modeling of neurodegenerative diseases
Chopra, M., Seth, E., Mehra, S., & Sobti, R. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90583-1.00005-2
Entstehung und Prävention altersassoziierter neurodegenerativer Erkrankungen
Calabrese, P. (2022) · Springer eBooks · doi:10.1007/978-3-662-61417-4_16 · Cited by 1
Approche clinique des troubles neurocognitifs des pathologies dégénératives
Corneille, L., & Félician, O. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.01.015
Crichton, R. R., & Ward, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118553480.ch07
(2014) · Wiley eBooks · doi:10.1002/9781118645840.refs
Zampar, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9004
„Ex vivo” Replikation des pathogenen Prion Proteins
Heinig, L. (2007) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-186
Schuit, F. C. (2010) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8225-5_9
Gene-Environment Interactions in Neurodegenerative Diseases
Hannan, A. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-444-63951-6.00076-0
Schuit, F. C. (2015) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0620-6_9
Matthews, B. R. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.009
Acupuncture for Parkinson's Disease
Wang, L., Xie, Y., Zhang, S., & Wu, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006236.pub2 · Cited by 1
Disease Influence on BBB Transport in Neurodegeneration
de Lange, E. C. M. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_22
Challenges and Potential Therapies Associated with Onset and Progression of Alzheimer’s Disease
Meena, M., Jhalora, V., & Bist, R. (2021) · Annals of Health and Health Sciences · doi:10.5958/2322-0422.2021.00005.9
Sobti, N., & Bayraktar, G. (2023) · Journal of Student Research · doi:10.47611/jsr.v11i3.1644 · Cited by 1
รัตนพันธ์, จ., & ลิขิตเจริญ, ย. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.1609
Fundamentals of neurorehabilitation
Nilsen, D. M., Winterbottom, L., & Goldberg, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91931-9.00013-x
Sirati, N. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/2077
Hemodiyaliz Hastalarında Kateter İlişkili Enfeksiyon Etkenleri
Kaya, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1668
Menstrüel Siklusun Evrelerinin Uyku, İştah ve Vücut Ağırlığı Üzerine Etkileri
Özüpek, G., & Altay, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1671
Metabolik Hastalıklarda Asprosinin Rolü
Akçılar, R. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1669
Metisilin Dirençli Staphylococcus aureus (MRSA)
Sağlam, M., Kılıç, İ. H., & Zer, Y. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1677
Fahrioğlu, S. L., Yılmaz, İ., & İlgi, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1675
İyonlaştırıcı Olmayan Radyasyonun Yaşamımızdaki Yeri
Yavaş, M. C. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1673
Amiloid Beta Peptidler: in-vitro Alzheimer Hastalığı Toksisite Modellerinde Kullanımları
Kurt, S., & Çam, F. S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1678
Dalak Anatomisi ve Klinik Önemi
Erbek, E., & BOLATLI, G. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1674
Gebelikte Parasetamol (Asetaminofen) Kullanımı Güvenli mi?
Şen, F. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1676
Köse, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1670
Coşar, A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1672 · Cited by 1
Sağlık Bilimleri Araştırmaları: Temel Tıp- IV
Kaya, H., Ibrahim Halil GAZIANTEP UNIVERSITY KILIC, Akçılar, R., Köse, H., Özüpek, G., Altay, İ. S., Coşar, A., Yavaş, M. C., Erbek, E., BOLATLI, G., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384
Yerel bir virüsten Yeni Bir Epidemiye mi? Maymun Çiçeği Virüsü (Monkeypox) Virüsü Yapısı
Bozlak, Ç. E. B. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1681
Salmonella spp. Enfeksiyonları
Gümüşburun, S. A., Demirdöğen, Y., Vural, U., Boyraz, E. F., & Eslami, M. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1679
Effects of Radiofrequency Radiations on the Male Reproductive System
Yavaş, M. C. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1680
Ye, C., Ho, R., Moberg, K. H., & Zheng, J. Q. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.06.583747
Ye, C., Ho, R., Moberg, K. H., & Zheng, J. Q. (2024) · eLife · doi:10.7554/elife.97908.1
Ye, C., Ho, R., Moberg, K. H., & Zheng, J. Q. (2024) · eLife · doi:10.7554/elife.97908.2 · Cited by 1
IGF-II conjugated nanocarrier for brain targeting
Akotkar, L., Aswar, U. M., Shruti, S. D., Tushar, S., & Dhanshree, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00004-2
Nanoscale engineering for biomedical applications
Abraham, T. R., Ganesh, K. M., Bhaskar, S., & Thomas, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21691-6.00020-2 · Cited by 1
Williams, K. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00205-0
Future Directions and Challenges in Enzyme Research for Neurodegenerative Diseases
Rathi, K. M., Pingat, P., & Firdous, S. M. (2024) · Springer eBooks · doi:10.1007/978-981-97-6822-6_10 · Cited by 1
Prädiktive Diagnostik neurodegenerativer Erkrankungen
Weydt, P., & Bernsen, S. (2024) · Springer eBooks · doi:10.1007/978-3-662-69739-9_7
Scouting Biomarkers for Alzheimer’s Disease via Network Analysis of Exosome Proteomics Data
Sagonas, A., Apostolakou, A. E., Litou, Z. I., Antonelou, M. H., & Iconomidou, V. A. (2025) · BioMedInformatics · doi:10.3390/biomedinformatics5020019
“More specifically, evidence supports the possible involvement of the mTOR signaling pathway (has04150) in disease progression [53–57].”
Adusumilli, S., Mathe, M. M., Shandilya, J., & Nayak, T. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.28.662125
Cardim-Pires, T. R., Martins, A. D. S., Guimarães, F. V., Mattos, T. R. F., Saraiva, E. M., Silva, P., & Foguel, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.26.678871
Kronvold, C., Sperling, S., Möller, S., Grauslund, J., & Stokholm, L. (2025) · Acta Ophthalmologica · doi:10.1111/aos.70039
Singh, S., Singh, P. B. R. P., P, V. M., Vijaivasudev, M. J., Kumar, R., & Malik, I. (2026) · NAR Molecular Medicine · doi:10.1093/narmme/ugaf044
“NDs affect millions of individuals worldwide, and their prevalence is expected to surge dramatically as the average global life expectancy increases [ 1 , 2 ].”
Xie, R., Zeng, A., & Pan, D. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11357055
Zha, Z., Jin, J., Margolis, R. L., & Taliun, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.29.702657
Schindler, M. (2010) · theses.fr (ABES) · doi:10.70675/cee355aez4f3cz472bz8dd9z2880a141df1c
Arlicot, N. (2009) · theses.fr (ABES) · doi:10.70675/8c4fde33z9347z4619z9a5fz312d47055e8b · Cited by 1
Ketogenic diet impacts Blood-Brain Barrier physiology : implications for Alzheimers's disease
Corsi, M. (2018) · theses.fr (ABES) · doi:10.70675/36cd4c36z2faaz4535zaafdz8f54069c5015
Pyrimidine and NAD salvage pathways : unexpected allies in the maintenance of genome stability
Silveira, S. C. (2018) · theses.fr (ABES) · doi:10.70675/d8951764z7ae2z4d5eza2e1z0b24bea9f901
Novel FUS and CHCHD10 models to investigate pathogenic mechanisms in Amyotrophic Lateral Sclerosis
Bourefis, A.-R. (2019) · theses.fr (ABES) · doi:10.70675/45ab8515z9859z430fzb472z306dd61206c8 · Cited by 1
Shachykov, A. (2019) · theses.fr (ABES) · doi:10.70675/6ccb58ccz2bfbz4e79z9c20zdc71113539ab · Cited by 1
“It is the second most common neuro-degenerative disease of adult onset [27].”
BackgroundRengifo-Gonzalez, J. C. (2020) · theses.fr (ABES) · doi:10.70675/e4d4c819zb9c3z4abdza47cz73bc506bbee3
Bouvier‐Müller, A. (2020) · theses.fr (ABES) · doi:10.70675/2097d129z95aaz45f5zbf91z199fddefb42c
Terras, F. (2020) · theses.fr (ABES) · doi:10.70675/872df6d1ze1b9z4a8dzb02dzad4656ff10f0 · Cited by 1
Fonctions mitochondriales de la protéine Optineurine : neurodégénérescence et cancer
D’Urso, B. (2025) · theses.fr (ABES) · doi:10.70675/fe933860ze386z4ca5zaa6fzfcd35c62ce81
Buttifant, E., Allogmanny, S., & Probst, Y. (2026) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70250
Šmon, J., Juković, M., Kršanac, M., Samardžija, B., Paska, A. V., Žerovnik, E., Kouter, K., & Bradshaw, N. J. (2026) · Biomolecules · doi:10.3390/biom16050733
“Rare but severe cases of neurodegenerative disorders have been linked to familial clustering of pathogenic variations (Bertram and Tanzi, 2005, [170]; Raguseo et al., 2023, [171]).”
Vishwakarma, H., Chauhan, A., Kaur, L., & Awasthi, A. (2026) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgag060
Zong, C., Dong, Y., Yu, X. L., He, Y., Zhang, X., & Gao, K. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70350
Role of endoplasmic reticulum stress in angiogenesis
Bhardwaj, S., Reyaz, H., & Jain, B. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41553-1.00002-5
Sun, Z., Peng, J., Feng, Z., Wang, X., Long, H., Qi, S., Li, L., Li, M., Yung, K. K. L., Cheung, K., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120437
Wang, S., Lin, Y., Che, Y., Zhao, J., Xu, L., He, W., & Zhang, W. (2026) · Archives of Medical Science · doi:10.5114/aoms/219499
Fuior, R., Luca, C. M., Ciorap, R., Andritoi, D.-I., Moruz, M., Onita, C. A., & Corciovă, C. (2026) · doi:10.3390/engproc2026148020
A De Novo 16p13.3 Triplication Underlying Early‐Onset Complex Neurodegeneration
Zheng, Z.-H., Yuan, R., Fang, M.-K., Lin, H., Xiao, W.-H., Qiu, Y., Cheng, B., Lin, W. C., Gan, S., Wang, N., et al. (2026) · Movement Disorders · doi:10.1002/mds.70540
The microbiota–proteostasis axis: implications in neurodegenerative diseases
Czyż, D. M., & Brown, B. M. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2025.0265
“The onset of PCDs is commonly attributed to uncontrollable variables such as ageing [3 ], genetic predisposition [4 ] and environmental stressors [5 ]; however, their aetiology is far more complex and remains elusive.”
Modeling human neurodegeneration with iPSCs: opportunities, limitations, and the challenge of aging
Wang, S., Elia, L., Liu, W., & Finkbeiner, S. M. (2026) · Journal of Clinical Investigation · doi:10.1172/jci209602
“Virtually every gene that causes dominant neurodegeneration through rare, high-penetrance mutations also harbors weaker common variants that confer sporadic disease risk (12).”
Metadata
- Authors
- Bertram, L.
- Affiliations
- Harvard University (US)
- Corresponding author
- Bertram, L.
- ORCID
- Bertram, L.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-06-01
- Volume
- 115
- Issue
- 6
- Pages
- 1449-1457
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1137006
- OpenAlex
- W2110054485
- Cited by
- 680
- References
- 106
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 40 · 2023: 48 · 2022: 48 · 2021: 40 · 2020: 44 · 2019: 37 · 2018: 46 · 2017: 41 · 2016: 36 · 2015: 20 · 2014: 25 · 2013: 25 · 2012: 34
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Massachusetts General Hospital
- National Alliance for Research on Schizophrenia and Depression
- Deutsche Forschungsgemeinschaft
- National Institute on Aging
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- neurodegenerative diseases, genetic epidemiology, Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, frontotemporal dementia, amyotrophic lateral sclerosis, Huntington's disease, prion disease, common disease-common variant hypothesis, complex disease genetics, familial aggregation, genetic risk factors, single nucleotide polymorphisms, gene-environment interaction, genetic heterogeneity, pathogenesis, amyloid precursor protein, alpha-synuclein, tau protein
- MeSH terms
- Chromosome Mapping, Nerve Degeneration, Molecular Epidemiology, Neurodegenerative Diseases, Genetic Predisposition to Disease, Physical Chromosome Mapping
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.